FDA approvals are critical milestones for pharmaceutical companies, often leading to increased stock prices due to the potential for new revenue streams. Given the significance of Winrevair's approval for a serious condition like pulmonary arterial hypertension, it's likely to have a positive impact on Merck's financial performance and investor sentiment in the short term.